学会発表
HER2陽性乳癌での術前Dual-HER2 blockage 療法の長期予後検討(JBCRG-16試験)
Shoichiro Ohtani, Norikazu Masuda, Naohito Yamamoto, Hiroji Iwata, Hiroko Bando, Tomoyuki Aruga, Eriko Tokunaga, Tomomi Fujisawa, Toshimi Takano, Kennichi Inoue, Nobuyasu Suganuma, Masahiro Takada, Kenjiro Aogi, Kenichi Sakurai, Hideo Shigematsu, Katsumasa Kuroi, Hironori Haga, Shinji Ohno, Satoshi Morita, Masakazu Toi
2022年7月 第30回日本乳癌学会学術総会 厳選口演 ハイブリッド
日本国内における進行・再発乳癌患者レジストリ構築 – Advanced Breast Cancer Database プロジェクト –
Yasuaki Sagara, Naoki Niikura, Shigehira Saji, Shogo Nakamoto, Eriko Tokunaga, Yoshie Hasegawa, Nobuhiro Shibata, Hidetoshi Kawaguchi, Kokoro Kobayashi, Tsutomu Takashima, Masahiro Takada, Mitsuchika Hosoda, Minoru Miyashita, Hiraku Kumamaru, Norikazu Masuda
2022年7月 第30回日本乳癌学会学術総会 厳選口演 ハイブリッド
転移・再発乳癌における遺伝子パネル検査F1CDxとF1LCDxの治療方針決定に与える影響を検討する観察研究
Hiroshi Tada, Hiroko Masuda, Yayoi Adachi, Tsuguo Iwatani, Yasuaki Uemoto, Yoko Otani, Yukiko Kajiwara, Dai Kitagawa, Takahiro Kogawa, Yasuaki Sagara, Tadahiko Shien, Yuko Tanabe, Maki Tanioka, Masaya Hattori, Fumikata Hara, Hiroyuki Yasojima, Kenichi Yoshimura, Hiroji Iwata, Norikazu Masuda
2022年7月 第30回日本乳癌学会学術総会 ポスター ハイブリッド
Genomic profile and response prediction of eribulin mesylate based neoadjuvant chemotherapy in triple negative breast cancer patients
Tomomi Nishimura, Norikazu Masuda, Kosuke Kawaguchi, Masahiro Takada, Yurina Maeshima, Sunao Tanaka, Ravindranath M. Velaga, Yuichiro Kikawa, Takayuki Kadoya, Hiroko Bando, Rikiya Nakamura, Yutaka Yamamoto, Takayuki Ueno, Hiroyuki Yasojima, Hiroshi Ishiguro, Satoshi Morita, Shinji Ohno, Hironori Haga, Seishi Ogawa, Masakazu Toi
2021.9 ESMO Poster WEB
Immune microenvironment, homologous recombination deficiency and therapeutic response to neoadjuvant chemotherapy in triple negative breast cancer: JBCRG22 TR
Takayuki Ueno, Shigehisa Kitano, Norikazu Masuda, Daiki Ikarashi, Makiko Yamashita, Takayuki Kadoya, Hiroko Bando, Takashi Yamashita, Shoichiro Ohtani, Shigenori Nagai, Takahiro, Nakayama, Masato Takahashi, Shigehira Saji, Kenjiro Aogi, Ravindranath M. Velaga, Kosuke Kawaguchi, Satoshi Morita, Hironori Haga, Shinji Ohno, Masakazu Toi
2021.9 ESMO Poster WEB
Longitudinal alteration of cytokine profile in the peripheral blood and clinical response for neoadjuvant chemotherapy in triple-negative breast cancer patients (Translational Research of the JBCRG-22 Trial)
Kosuke Kawaguchi, Norikazu Masuda, Sunao Tanaka, Hiroko Bando, Tomomi Nishimura, Takayuki Kadoya, Takashi Yamanaka, Shigeru Imoto, Ravindranath M. Velaga, Nobuko Tamura, Tomoyuki Aruga, Yurina Maeshima, Masahiro Takada, Eiji Suzuki, Takayuki Ueno, Seishi Ogawa, Hironori Haga, Shinji Ohno, Satoshi Morita, Masakazu Toi
2021.9 ESMO Poster WEB
Long-term follow-up of neoadjuvant dual anti-HER2 therapy with trastuzumab and lapatinib plus paclitaxel, with or without endocrine therapy for HER2‐positive primary breast cancer: Neo-LaTH (JBCRG-16) study.
Tomomi Fujisawa, Norikazu Masuda, Naohito Yamamoto, Hiroji Iwata, Hiroko Bando, Tomoyuki Aruga, Eriko Tokunaga, Shoichiro Ohtani, Toshimi Takano, Kenichi Inoue, Nobuyasu Suganuma, Masahiro Takada, Kenjiro Aogi, Kenichi Sakurai, Hideo Shigematsu, Katsumasa Kuroi, Hironori Haga, Shinji Ohno, Satoshi Morita, Masakazu Toi
2021.9 ESMO Poster WEB
PRECIOUS: Pertuzumab re-treatment for HER2-positive locally advanced/metastatic breast cancer (JBCRG-M05)
Tatsuya Toyama, Yutaka Yamamoto, Hiroji Iwata, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Takashi Yamanaka, Toshimi Takano, Masahiro Kashiwaba, Norikazu Masuda, Koichiro Tsugawa, Yoshie Hasegawa, Kenji Tamura, Hiroshi Tada, Naruto Taira, Fumikata Hara, Shigehira Saji, Satoshi Morita, Masakazu Toi, Shinji Ohno
2021.3 JSMO Oral WEB
A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study
Yutaka Yamamoto, Hiroji Iwata, Taira Naruto, Norikazu Masuda, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano, Masahiro Kashiwaba, Koichiro Tsugawa, Yoshie Hasegawa, Kenji Tamura, Hiroshi Tada, Fumikata Hara, Shigehira Saji, Satoshi Morita, Masakazu Toi, Shinji Ohno, Japan Breast Cancer Research Group.
2020.12 SABCS Oral WEB
Influence of the adjuvant hormonal therapy on hormone sensitivity and survival outcomes in ER+ and HER2−advanced breast cancer: a subgroup analysis of the JBCRG-C06 Safari study
Takahiro Nakayama, Hidetoshi Kawaguchi, Norikazu Masuda, Shigehira Saji, Yutaka Yamamoto, Kenjiro Aogi, Keisei Anan, Yoshinori Ito, Shoichiro Ohtani, Nobuaki Sato, Toshimi Takano, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Miki Yamaguchi, Hiroko Yamashita, Toshinari Yamashita, Daisuke Yotsumoto, Satoshi Morita, Masakazu Toi, Shinji Ohno
2020年10月 第28回日本乳癌学会学術総会 ポスター WEB